Skip to main content

Advertisement

Advertisement

WHO advisory panel recommends extending use of Pfizer vaccine to 5-11 year olds

WHO advisory panel recommends extending use of Pfizer vaccine to 5-11 year olds
The recommended dosage for the younger population is 10 micrograms instead of 30 micrograms offered to those 12 years and older.

GENEVA — The World Health Organization's advisory panel on Friday (Jan 21) recommended extending the use of a reduced dosage of Pfizer and German partner BioNTech's Covid-19 vaccine to children aged five to 11 years old.

The recommendation comes after the Strategic Advisory Group of Experts (Sage) on immunisation held a meeting on Wednesday to evaluate the companies' vaccine. The vaccine is currently recommended for use in people aged 12 years and above.

The recommended dosage for the younger population is 10 micrograms instead of 30 micrograms offered to those 12 years and older.

"This age group (5-11) is in the lowest priority use group for vaccination except for children who have co-morbidities," Sage chairman Alejandro Cravioto said.

The panel also recommended that booster doses of Covid-19 vaccine should be administered four to six months after the completion of the primary series, in high-priority groups like older adults and health workers. REUTERS

Related topics

Pfizer-BioNTech Covid-19 Covid-19 vaccine

Read more of the latest in

Advertisement

Popular

Advertisement

Stay in the know. Anytime. Anywhere.

Subscribe to get daily news updates, insights and must reads delivered straight to your inbox.

By clicking subscribe, I agree for my personal data to be used to send me TODAY newsletters, promotional offers and for research and analysis.

Aa